Biolife Sciences (Biolife Sciences) Scaled Net Operating Assets : 0.76 (As of May. 2008)

View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Biolife Sciences's operating assets for the quarter that ended in May. 2008 was $3.00 Mil. Biolife Sciences's operating liabilities for the quarter that ended in May. 2008 was $0.60 Mil. Biolife Sciences's Total Assets for the quarter that ended in Feb. 2008 was $3.17 Mil. Therefore, Biolife Sciences's scaled net operating assets (SNOA) for the quarter that ended in May. 2008 was 0.76.

Biolife Sciences Scaled Net Operating Assets Historical Data

The historical data trend for Biolife Sciences's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Scaled Net Operating Assets Chart

Biolife Sciences Annual Data

Trend

Nov04

Nov05

Nov06

Nov07

Scaled Net Operating Assets

2.95

1.54

0.67

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
Scaled Net Operating Assets	Get a 7-Day Free Trial										0.83	0.72	0.66	0.61	0.76

Competitive Comparison of Biolife Sciences's Scaled Net Operating Assets

For the Medical Instruments & Supplies subindustry, Biolife Sciences's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biolife Sciences's Scaled Net Operating Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biolife Sciences's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Biolife Sciences's Scaled Net Operating Assets falls into.

Biolife Sciences Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Biolife Sciences's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Nov. 2007 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Nov. 2007 )
=	(Operating Assets (A: Nov. 2007 )	-	Operating Liabilities (A: Nov. 2007 ))	/	Total Assets (A: Nov. 2006 )
=	(3.353	-	1.042)	/	3.474
=	0.67

where

	Operating Assets		(A: Nov. 2007 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	3.762	-	0.409
=	3.353

	Operating Liabilities		(A: Nov. 2007 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	3.702	-	0.206	-	2.454
=	1.042

Biolife Sciences's Scaled Net Operating Assets (SNOA) for the quarter that ended in May. 2008 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: May. 2008 )
=	(Operating Assets (Q: May. 2008 )	-	Operating Liabilities (Q: May. 2008 ))	/	Total Assets (Q: Feb. 2008 )
=	(3.001	-	0.602)	/	3.174
=	0.76

where

	Operating Assets		(Q: May. 2008 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	3.041	-	0.04
=	3.001

	Operating Liabilities		(Q: May. 2008 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	3.46	-	0.421	-	2.437
=	0.602

Biolife Sciences Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052

Website

https://www.biolifesciences.com

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.

Executives

Arthur Viola

director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020